Lyra Therapeutics Growth Metrics (2021-2025) | LYRA

Growth Metrics Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) 7.49M-12.43M-0.14M-0.07M0.12M11.90M-0.03M-0.46M-0.32M0.51M-0.04M0.40M-1.79M-9.40M
EBITDA Margin Growth (3y) (Quarter) 7.29M-0.02M-0.21M-0.13M-1.98M3.00M
EBITDA Margin (QoQ) (Quarter) 7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.61M-0.38M0.20M0.08M0.06M0.06M-1.99M-7.54M
EBIT Margin Growth (1y) (Quarter) 7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M0.58M-0.04M0.34M-1.86M-9.62M
EBIT Margin Growth (3y) (Quarter) 7.28M-0.04M-0.23M-0.21M-2.08M3.61M
EBIT Margin (QoQ) (Quarter) 7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.09M0.06M820.00-2.01M-7.67M
EBT Margin Growth (1y) (Quarter) 7.49M-12.43M-0.14M-0.07M0.12M11.89M-0.03M-0.46M-0.32M0.51M-0.05M0.40M-1.78M-9.40M
EBT Margin Growth (3y) (Quarter) 7.29M-0.02M-0.21M-0.13M-1.98M3.00M
EBT Margin (QoQ) (Quarter) 7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.62M-0.38M0.20M0.08M0.06M0.06M-1.99M-7.53M
Enterprise Value Growth (1y) (Quarter) -77.30%-115.48%-146.78%35.94%6.62%-4.89%-5.92%11.38%48.42%61.04%64.38%57.14%58.87%60.83%
Enterprise Value Growth (3y) (Quarter) -0.22%4.15%2.35%37.57%41.70%45.70%
Enterprise Value (QoQ) (Quarter) 26.03%-259.16%9.08%10.80%15.28%6.76%-32.54%-0.20%14.45%21.99%22.85%24.32%21.79%6.15%25.95%27.94%
FCF Margin Growth (1y) (Quarter) 6.54M-10.58M-0.13M-0.15M0.05M9.74M-0.04M-0.02M-0.69M0.81M-0.05M-0.03M-1.99M-8.26M
FCF Margin Growth (3y) (Quarter) 5.89M-0.04M-0.23M-0.20M-2.64M2.28M
FCF Margin (QoQ) (Quarter) 6.34M0.25M0.10M-0.15M-10.78M10.70M0.07M0.06M-1.09M0.92M0.10M-0.62M0.41M0.06M0.12M-2.58M-5.86M
Net Margin Growth (1y) (Quarter) 7.49M-12.43M-0.14M-0.07M0.12M11.89M-0.03M-0.46M-0.32M0.51M-0.05M0.40M-1.78M-9.40M
Net Margin Growth (3y) (Quarter) 7.29M-0.02M-0.21M-0.13M-1.98M3.00M
Net Margin (QoQ) (Quarter) 7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.62M-0.38M0.20M0.08M0.06M0.06M-1.99M-7.54M
Operating Margin Growth (1y) (Quarter) 7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M0.58M-0.04M0.34M-1.86M-9.62M
Operating Margin Growth (3y) (Quarter) 7.28M-0.04M-0.23M-0.21M-2.08M3.61M
Operating Margin (QoQ) (Quarter) 7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.09M0.06M820.00-2.01M-7.67M
Return on Assets Growth (1y) (Quarter) 23.0035.002.00-6.001.0010.00-30.00-62.00-81.00-81.0015.0044.0056.00
Return on Assets Growth (3y) (Quarter) -58.00-36.00-14.00-25.00-24.00
Return on Assets (QoQ) (Quarter) -22.0036.0014.00-4.00-10.003.005.003.00-1.00-37.00-27.00-16.00-1.0058.003.00-4.00
Return on Capital Employed Growth (1y) (Quarter) 45.0093.00-1.00-14.00-4.0011.00-40.00-78.00-101.00-104.0011.0050.0059.00
Return on Capital Employed Growth (3y) (Quarter) -60.000.00M-31.00-42.00-46.00
Return on Capital Employed (QoQ) (Quarter) -62.0098.0016.00-7.00-14.004.003.003.000.00M-48.00-34.00-19.00-3.0068.005.00-11.00
Return on Equity Growth (1y) (Quarter) 43.0084.005.00-13.00-9.00-1.00-113.00-311.00-508.00-946.00-0.00M0.00M965.00
Return on Equity Growth (3y) (Quarter) -473.00-863.00-0.00M0.00M448.00
Return on Equity (QoQ) (Quarter) -59.0087.0024.00-9.00-18.007.006.00-5.00-10.00-104.00-191.00-202.00-448.00-391.000.00M-0.00M
Return on Invested Capital Growth (1y) (Quarter) -521.00-969.00-0.00M0.00M0.00M
Return on Invested Capital (QoQ) (Quarter) -11.00-107.00-198.00-205.00-458.00-462.000.00M-0.00M
Return on Sales Growth (1y) (Quarter) 0.07M-0.12M-0.00M-674.000.00M0.12M-256.00-0.00M-0.00M0.01M-450.000.00M-0.02M-0.09M
Return on Sales Growth (3y) (Quarter) 0.07M-228.00-0.00M-0.00M-0.02M0.03M
Return on Sales (QoQ) (Quarter) 0.07M0.00M-191.00-0.00M-0.13M0.13M555.00533.00-0.01M0.01M-0.00M0.00M836.00583.00607.00-0.02M-0.08M